carident (100 mg + 150 mg + 80 mg)/g maść
chema-elektromet spółdzielnia pracy - framycetini sulfas + papainum + natrii benzoas - maść - (100 mg + 150 mg + 80 mg)/g
masti veyxym (8 mg + 8 mg + 4 mg + 100 000 iu + 120 mg)/10 g zawiesina dowymieniowa
veyx-pharma gmbh - witamina e + trypsyna + chymotrypsyna + vitaminum a + papainum - zawiesina dowymieniowa - (8 mg + 8 mg + 4 mg + 100 000 iu + 120 mg)/10 g - bydło
irynotekan chlorowodorku qilu 20 mg/ml koncentrat do sporządzania roztworu do infuzji
qilu pharma spain s.l. - irinotecani hydrochloridum trihydricum - koncentrat do sporządzania roztworu do infuzji - 20 mg/ml
tranexamic acid tillomed 500 mg tabletki powlekane
laboratorios tillomed spain s.l.u. - acidum tranexamicum - tabletki powlekane - 500 mg
brinzolamide accord 10 mg/ml krople do oczu, zawiesina
accord healthcare polska sp. z o.o. - brinzolamidum - krople do oczu, zawiesina - 10 mg/ml
nexobrid
mediwound germany gmbh - proteolytic enzymes enriched in bromelain - oczyszczenie - preparaty do leczenia ran i owrzodzeń - preparat nexobrid jest wskazany do usuwania strupów u osób dorosłych z głębokimi oparzeniami termicznymi częściowej i pełnej grubości.
ex-pain 20 mg/tabletkę tabletka
nordpharm poland sp. z o.o. - carprofenum - tabletka - 20 mg/tabletkę - pies
ex-pain 50 mg/tabletkę tabletka
nordpharm poland sp. z o.o. - carprofenum - tabletka - 50 mg/tabletkę - pies
ex-pain 100 mg/tabletkę tabletka
nordpharm poland sp. z o.o. - carprofenum - tabletka - 100 mg/tabletkę - pies
spikevax (previously covid-19 vaccine moderna)
moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - szczepionki - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.